Skip to content
The federal government today released two calls for public input on how the U.S. can support biotech innovation to help strengthen the industry while […]
Biden Administration seeks public input on how to support biotech Read More »
On Friday, Mexican officials proposed amendments to the plan to ban imports of biotech corn from the U.S. and said they expect to reach
Mexico proposes amendments to biotech corn ban Read More »
The process of holding clinical trials and gaining FDA approval takes up much of the time and expense involved in drug development, which can
BIO aids global harmonization, helping speed cures to patients Read More »
One-third of parents now oppose public schools requiring students to get routine childhood vaccines against measles and other illnesses, an increase in opposition to
More parents oppose routine childhood vaccines since 2019, survey shows Read More »
The Biotechnology Innovation Organization (BIO) hosted leaders from industry and governments in the U.S. and Africa in an effort to build collaboration against cancer
BIO hosts industry and government leaders in Africa Summit side event targeting cancer Read More »
The Accelerated Approval (AA) pathway, one of the U.S. Food and Drug Administration’s (FDA) most valuable tools that allow drugs to launch in the
FDA cuts back on Accelerated Approval pathway in 2022 Read More »
One in eight global deaths in 2019 was caused by common bacterial infections, which are the second leading cause of death worldwide, right after
Common bacterial infections behind every eight death in the world in 2019, study says Read More »
The 2022 midterms are officially behind us – so, what happened, and what does biotech need to know going into the new year? We
2022 midterms recap: what happened and what the results mean for biotech Read More »
The 2023 appropriations legislation currently under debate in Congress should require the U.S. Food and Drug Administration (FDA) to clarify its policy on genome
Spending bill should require FDA to clarify genome editing policy, lawmakers say Read More »
In a development hailed as a possible cancer breakthrough, Moderna announced Tuesday that its experimental personalized cancer vaccine, employing the mRNA technology the company developed
Moderna’s personalized mRNA melanoma vaccine achieves positive results Read More »
